FZD6 and pulmonary fibrosis: Recent work demonstrated that bone marrow-MSC-derived EVs suppress fibroblast proliferation and lung fibrosis by downregulating Frizzled Class Receptor 6 (FZD6) expression in fibroblasts through miR-29b-3p both in vitro and in vivo [90].